Table 6.
MRI features | Risk of high-grade STS | |||
---|---|---|---|---|
Lesion heterogeneity in ≥2/3 of total tumour volume on FS images | Tumour enhancement (>51%) on contraste-enhanced T1 | Presence of peritumoural enhancement on contrast-enhanced T1 |
High
two or three signs |
Low/moderate
0 or one sign |